Your browser doesn't support javascript.
loading
Neutralization susceptibility of B subtype variant B" primary HIV-1 isolates. The HEC/FIOCRUZ AIDS Clinical Research Group.
Bongertz, V; Costa, C I; Guimarães, M L; Grinsztejn, B; João Filho, E C; Galvão-Castro, B; Morgado, M G.
Afiliação
  • Bongertz V; Department of Immunology, IOC, Oswaldo Cruz Foundation, Rio de Janeiro, RJ, Brazil.
Scand J Immunol ; 47(6): 603-8, 1998 Jun.
Article em En | MEDLINE | ID: mdl-9652830
Susceptibility to autologous and heterologous neutralization of primary human immunodeficiency virus (HIV)-1 isolates belonging to subtype B, to the B"-variant of subtype B or to subtype F from infected individuals residing in Rio de Janeiro was assayed. A lower infectivity of the B"- and F isolates when compared to the classical B-subtype HIV-1 isolates was observed. Comparisons of neutralization susceptibilities were carried out for 19 B-subtype, 11 B"-variant and two F-subtype HIV-1 isolates with plasma from autologous and heterologous samples. Frequency of autologous neutralization was slightly lower for B-subtype isolates in comparison to B"-variant isolates. Heterologous intra-subtype neutralization was significantly lower for B-subtype than for the B"-variant or the F-subtype isolates. While B-subtype isolates were neutralized by most anti-F-subtype plasma, F-subtype isolates, although most susceptible to F-subtype antibodies, were highly susceptible to neutralization by anti-B-subtype antibodies. Cross-neutralization for B"-variant and B-subtype isolates was not as extensive as observed for B- and F-subtype isolates. However, the results presented indicate a quite extensive cross-neutralization between Brazilian HIV-1 isolates.
Assuntos
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antígenos HIV / HIV-1 Limite: Humans Idioma: En Revista: Scand J Immunol Ano de publicação: 1998 Tipo de documento: Article País de afiliação: Brasil País de publicação: Reino Unido
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antígenos HIV / HIV-1 Limite: Humans Idioma: En Revista: Scand J Immunol Ano de publicação: 1998 Tipo de documento: Article País de afiliação: Brasil País de publicação: Reino Unido